Cargando…
多西他赛与吉非替尼序贯应用对人肺腺癌细胞H1975存活及凋亡通路的研究
BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib and erlotinib show promising therapeutic effects in patients with advanced non-small cell lung cancer (NSCLC). However, despite an initial response to EGFR-TKIs treatment among respo...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999877/ https://www.ncbi.nlm.nih.gov/pubmed/22429575 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.03.01 |